1. Home
  2. NNVC vs CASI Comparison

NNVC vs CASI Comparison

Compare NNVC & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • CASI
  • Stock Information
  • Founded
  • NNVC 2005
  • CASI 1991
  • Country
  • NNVC United States
  • CASI China
  • Employees
  • NNVC N/A
  • CASI N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNVC Health Care
  • CASI Health Care
  • Exchange
  • NNVC Nasdaq
  • CASI Nasdaq
  • Market Cap
  • NNVC 24.8M
  • CASI 24.9M
  • IPO Year
  • NNVC N/A
  • CASI 1996
  • Fundamental
  • Price
  • NNVC $1.26
  • CASI $1.24
  • Analyst Decision
  • NNVC
  • CASI Strong Buy
  • Analyst Count
  • NNVC 0
  • CASI 1
  • Target Price
  • NNVC N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • NNVC 477.8K
  • CASI 25.3K
  • Earning Date
  • NNVC 11-14-2025
  • CASI 11-14-2025
  • Dividend Yield
  • NNVC N/A
  • CASI N/A
  • EPS Growth
  • NNVC N/A
  • CASI N/A
  • EPS
  • NNVC N/A
  • CASI N/A
  • Revenue
  • NNVC N/A
  • CASI $26,846,000.00
  • Revenue This Year
  • NNVC N/A
  • CASI N/A
  • Revenue Next Year
  • NNVC $133.33
  • CASI N/A
  • P/E Ratio
  • NNVC N/A
  • CASI N/A
  • Revenue Growth
  • NNVC N/A
  • CASI 21.72
  • 52 Week Low
  • NNVC $0.94
  • CASI $1.09
  • 52 Week High
  • NNVC $2.23
  • CASI $5.32
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 38.51
  • CASI 36.04
  • Support Level
  • NNVC $1.37
  • CASI $1.15
  • Resistance Level
  • NNVC $1.56
  • CASI $1.48
  • Average True Range (ATR)
  • NNVC 0.21
  • CASI 0.11
  • MACD
  • NNVC -0.06
  • CASI -0.00
  • Stochastic Oscillator
  • NNVC 3.95
  • CASI 27.78

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: